BBCovid - Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses

Head :
CARROUEL Florence, Laboratory "Systemic Health Course", EA4129

Last update : 01/06/2021 | Version : 1 | ID : 73441

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses
Sign or acronym BBCovid
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CPP 2020.04.11 sept _20.04.06.46640, CNIL 2217601 v 0, ClinicalTrials.gov ID: NCT04352959
General Aspects
Medical area Infectious diseases
Study in connection with Covid-19 Yes
Scientific investigator(s) (Contact)
Name of the director CARROUEL
Surname Florence
Address Laboratory "Systemic Health Course", EA4129
Faculty of Medicine Laennec,
11 Rue Guillaume Paradin,
69372 LYON CEDEX 08
FRANCE
Email florence.carrouel@univ-lyon1.fr
Unit Laboratory "Systemic Health Course", EA4129
Organization University Lyon 1
Collaborations
Participation in projects, networks and consortia No
Funding
Governance of the database
Sponsor(s) or organisation(s) responsible Laboratory "Systemic Health Course", EA4129
Organisation status Public
Additional contact
Name of the contact BOMEL
Surname Eric
Email eric.bomel@ezus.univ-lyon1.fr
Main features
Type of database
Type of database Others
Database objective
Main objective Change from Baseline amount of SARS-CoV-2 in salivary samples at 7 days
Quantitative PCR experiments will be performed and a quantitative analysis of the salivary samples will be made
Inclusion criteria • Age: 18-70 years
• Clinical diagnosis of Covid-19 infection by the patient's general practitioner and hospital doctor
• Clinical signs started less than 48 hours ago.
• Virological confirmation: not necessary but possible.
• Understanding and acceptance of the trial.
• Written agreement to participate in the trial
Population type
Age Adolescence (13 to 18 years)
Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Population covered Sick population
Pathology I - Certain infectious and parasitic diseases
Gender Male
Woman
Geography area National
Data collection
Dates
Size of the database
Size of the database (number of individuals) < 500 individuals
Data
Database activity Data collection completed
Type of data collected Clinical data
Biological data
Clinical data (detail) Medical registration
Procedures
Followed pathology
Links to administrative sources No
Promotion and access
Promotion
Link to the document Carrouel et al Trial 2020.pdf
Access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05